Presynaptic GLP‐1 receptors enhance the depolarization‐evoked release of glutamate and GABA in the mouse cortex and hippocampus
- 19 December 2017
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 44 (2) , 148-157
Abstract
Glucagon‐like peptide‐1 receptors (GLP‐1Rs) have been shown to mediate cognitive‐enhancing and neuroprotective effects in the central nervous system. However, little is known about their physiological roles on central neurotransmission, especially at the presynaptic level. Using purified synaptosomal preparations and immunofluorescence techniques, here we show for the first time that GLP‐1Rs are localized on mouse cortical and hippocampal synaptic boutons, in particular on glutamatergic and GABAergic nerve terminals. Their activation by the selective agonist exendin‐4 (1–100 nM) was able to increase the release of either [3H]d‐aspartate or [3H]GABA. These effects were abolished by 10 nM of the selective GLP1‐R antagonist exendin‐3 (9–39) and were prevented by the selective adenylyl cyclase inhibitor 2′,5′‐dideoxyadenosine (10 µM), indicating the involvement of classic GLP‐1Rs coupled to Gs protein stimulating cAMP synthesis.Our data demonstrate the existence and activity of presynaptic receptors for GLP‐1 that could represent additional mechanisms by which this neurohormone exerts its effects in the CNS. © 2017 BioFactors, 44(2):148–157, 2018Keywords
Funding Information
- University of Genoa
- Università degli Studi di Genova
This publication has 57 references indexed in Scilit:
- The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodentsPsychoneuroendocrinology, 2013
- Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretionEndocrine Connections, 2013
- Exenatide and the treatment of patients with Parkinson’s diseaseJournal of Clinical Investigation, 2013
- Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model MiceThe Journal of Neuroscience, 2012
- Exendin-4 treatment enhances L-DOPA evoked release of striatal dopamine and decreases dyskinetic movements in the 6-hydoxydopamine lesioned ratJournal of Pharmacy and Pharmacology, 2012
- Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTENJournal of Cell Science, 2012
- The major determinant of exendin‐4/glucagon‐like peptide 1 differential affinity at the rat glucagon‐like peptide 1 receptor N‐terminal domain is a hydrogen bond from SER‐32 of exendin‐4British Journal of Pharmacology, 2010
- GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and ParkinsonismProceedings of the National Academy of Sciences, 2009
- Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's diseaseJournal of Neuroinflammation, 2008
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976